SKI Market

Indian Indices

Nifty

24,334.20 -1.75
(-0.01%)

Sensex

80,242.24 -46.14
( -0.06%)

Bank Nifty

55,087.15 -304.10
( -0.55%)

Nifty IT

35,794.95 -125.45
( -0.35%)

Global Indices

Nasdaq

40,538.66 290.07
(0.72%)

Dow Jones

5,579.50 29.75
(0.54%)

Hang Seng

36,006.39 166.40
(0.46%)

Nikkei 225

8,463.46 46.12
(0.55%)

Forex

USD-INR

85.20 -0.17
(-0.20%)

EUR-INR

96.93 -0.07
(-0.07%)

GBP-INR

113.83 0.22
(0.19%)

JPY-INR

0.60 0.00
(0.27%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Advanced Enzyme Technologies Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

540025

INE837H01020

53.8173973

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ADVENZYMES

30.6

3241.76

EPS(TTM)

Face Value()

Div & Yield %

9.47

1.76

Back

dhansafal finserve ltd

KCD Industries India standalone net profit declines 81.25% in the September 2024 quarter

Nov 22,2024

Net profit of KCD Industries India declined 81.25% to Rs 0.15 crore in the quarter ended September 2024 as against Rs 0.80 crore during the previous quarter ended September 2023. Sales declined 74.53% to Rs 1.61 crore in the quarter ended September 2024 as against Rs 6.32 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	1.61	6.32	-75
OPM %	13.66	5.06	-
PBDT	0.22	0.80	-73
PBT	0.22	0.80	-73
NP	0.15	0.80	-81

24,334.20 -1.75 (-0.01%)

80,242.24 -46.14 ( -0.06%)

55,087.15 -304.10 ( -0.55%)

35,794.95 -125.45 ( -0.35%)

40,538.66 290.07 (0.72%)

5,579.50 29.75 (0.54%)

36,006.39 166.40 (0.46%)

8,463.46 46.12 (0.55%)

85.20 -0.17 (-0.20%)

96.93 -0.07 (-0.07%)

113.83 0.22 (0.19%)

0.60 0.00 (0.27%)